Vanguard Personalized Indexing Management
CDLX icon

Vanguard Personalized Indexing Management’s Cardlytics CDLX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,232
Closed -$12.9K – 2267
2026
Q1 		$12.9K Buy
+1,232
New +$12K ﹤0.01% 2144
2025
Q4 		– Sell
-1,063
Closed -$25.8K – 1997
2025
Q3 		$25.8K Buy
+1,063
New +$17.7K ﹤0.01% 1956

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Personalized Indexing Management's CDLX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management sold out of Cardlytics (CDLX) in Q2 2026, closing a stake of 1,232 shares — an estimated $12.9K sold.

Vanguard Personalized Indexing Management first reported a position in CDLX in Q3 2025 and held it in 2 quarters. The position peaked at $25.8K in Q3 2025. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Vanguard Personalized Indexing Management reported no remaining Cardlytics position as of Q2 2026 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 1,232 Cardlytics shares in Q2 2026, an estimated $12.9K.
  • Vanguard Personalized Indexing Management first reported a position in Cardlytics in Q3 2025 and held it in 2 quarters.
  • Vanguard Personalized Indexing Management's Cardlytics position peaked at $25.8K in Q3 2025.
  • 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.